Log In
Print this Print this

bempedoic acid (ETC-1002)

  Manage Alerts
Collapse Summary General Information
Company Esperion Therapeutics Inc.
DescriptionAMP-activated protein kinase (AMPK) activator and ATP citrate lyase (ACLY) inhibitor
Molecular Target AMP-activated protein kinase (AMPK) ; ATP citrate lyase (ACLY)
Mechanism of ActionAMP-activated protein kinase (AMPK) activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypercholesterolemia
Indication DetailsTreat hypercholesterolemia; Treat hypercholesterolemia and hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today